Matthew K Fust Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew K Fust.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew K Fust. Matthew K Fust is EVP & Chief Financial Officer in ONYX PHARMACEUTICALS INC ($ONXX).
Latest Insider Trading Transactions of Matthew K Fust
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 88.86 | 22,600 | 2,008,236 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 37.68 | 43,044 | 1,621,898 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 37.68 | 2,856 | 107,614 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 35.18 | 38,981 | 1,371,352 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 35.18 | 3,019 | 106,208 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 30.28 | 41,596 | 1,259,527 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 30.28 | 3,904 | 118,213 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | D | 34.48 | 41,450 | 1,429,196 | 0 | |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | D | 125.00 | 31,150 | 3,893,750 | 0 | 31.2 K to 0 (-100.00 %) |
| Oct 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | U | 125.00 | 9,153 | 1,144,125 | 31,150 | 40.3 K to 31.2 K (-22.71 %) |
| Aug 12 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 128.21 | 2,492 | 319,499 | 40,303 | 42.8 K to 40.3 K (-5.82 %) |
| Jul 29 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 130.50 | 6,043 | 788,612 | 42,795 | 48.8 K to 42.8 K (-12.37 %) |
| Jul 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 132.80 | 308 | 40,902 | 48,838 | 49.1 K to 48.8 K (-0.63 %) |
| Jul 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 132.80 | 1,243 | 165,070 | 48,961 | 50.2 K to 49 K (-2.48 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 10,269 | 354,075 | 41,450 | |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 98.70 | 6,000 | 592,200 | 50,204 | 56.2 K to 50.2 K (-10.68 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 97.54 | 4,269 | 416,398 | 56,204 | 60.5 K to 56.2 K (-7.06 %) |
| May 15 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 10,269 | 354,075 | 60,473 | 50.2 K to 60.5 K (+20.45 %) |
| Apr 16 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 95.15 | 1,347 | 128,167 | 50,204 | 51.6 K to 50.2 K (-2.61 %) |
| Apr 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 86.14 | 2,694 | 232,061 | 51,551 | 54.2 K to 51.6 K (-4.97 %) |
| Apr 03 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 86.13 | 1,167 | 100,514 | 54,245 | 55.4 K to 54.2 K (-2.11 %) |
| Apr 01 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | A | 88.86 | 22,600 | 2,008,236 | 22,600 | |
| Apr 01 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Grant | A | 0.00 | 8,000 | 0 | 55,412 | 47.4 K to 55.4 K (+16.87 %) |
| Mar 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 2,211 | 76,235 | 51,719 | |
| Mar 05 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 2,211 | 76,235 | 47,412 | 45.2 K to 47.4 K (+4.89 %) |
| Mar 04 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 10,000 | 344,800 | 53,930 | |
| Mar 04 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 77.12 | 15,000 | 1,156,800 | 45,201 | 60.2 K to 45.2 K (-24.92 %) |
| Mar 04 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 10,000 | 344,800 | 60,201 | 50.2 K to 60.2 K (+19.92 %) |
| Jan 11 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 7,112 | 245,222 | 63,930 | |
| Jan 11 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 85.83 | 3,299 | 283,153 | 50,201 | 53.5 K to 50.2 K (-6.17 %) |
| Jan 11 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Sell | S | 84.41 | 6,900 | 582,429 | 53,500 | 60.4 K to 53.5 K (-11.42 %) |
| Jan 11 2013 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 7,112 | 245,222 | 60,400 | 53.3 K to 60.4 K (+13.35 %) |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Option Exercise | M | 34.48 | 966 | 33,308 | 71,042 | |
| Nov 30 2012 | ONXX | ONYX PHARMACEUTICA ... | Fust Matthew K | EVP & Chief Financi ... | Buy | M | 34.48 | 966 | 33,308 | 53,123 | 52.2 K to 53.1 K (+1.85 %) |
Page: 1